Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06048159 · ClinicalTrials.gov registry record · NA

Transcranial Alternating Current Stimulation (tACS) for the Recovery of Phonological Short-Term Memory in Patients With Aphasia After Stroke

A NA study of Stroke and Aphasia, sponsored by Medical College of Wisconsin.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT06048159: Recruiting NA study of Stroke and Aphasia, sponsored by Medical College of Wisconsin.

NCT06048159 is a NA study of Stroke and Aphasia that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 120 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06048159, a NA study of Stroke and Aphasia, is actively recruiting participants, sponsored by Medical College of Wisconsin.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This study will assess the effects of transcranial alternating current stimulation (tACS) on language recovery after stroke.

Primary Outcome

Accuracy changes in a delayed sample-to-match task assessing phonological STM after tACS.

Conditions Studied

Interventions

  • DEVICE HD-tACS
  • DEVICE Sham HD-tACS

Study Locations (1)

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2023-11-06
Est. Completion 2033-01
Phase NA
Medical College of Wisconsin

447 total trials

What NCT06048159 shows while recruiting

NCT06048159 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which HD-tACS is the first listed.

NCT06048159 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06048159 about?

NCT06048159 is a clinical study titled "Transcranial Alternating Current Stimulation (tACS) for the Recovery of Phonological Short-Term Memory in Patients With Aphasia After Stroke". This study will assess the effects of transcranial alternating current stimulation (tACS) on language recovery after stroke.

What is the current status of trial NCT06048159?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-11-06. Estimated completion is 2033-01.

What conditions does trial NCT06048159 study?

This clinical trial studies the following conditions: Stroke, Aphasia.

What interventions are being tested in trial NCT06048159?

The interventions under investigation include: HD-tACS (DEVICE), Sham HD-tACS (DEVICE).

Who is sponsoring clinical trial NCT06048159?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06048159 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06048159's enrollment target sits among peer trials

120 117th of 454 higher than 329 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06048159, the US trial registry maintained by the National Library of Medicine. NCT06048159 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.